Dicerna Pharmaceuticals to Present at Upcoming Conferences  
2/28/2011 9:28:16 AM

WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (Dicerna), a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technologyâ„¢ and Dicer Substrate siRNA (DsiRNA) molecules, today announced that the company will be presenting at the following conferences in March and April: